{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:04:26Z","timestamp":1793804666344,"version":"4.6.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,1,5]],"date-time":"2012-01-05T00:00:00Z","timestamp":1325721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00198-011-1882-9","type":"journal-article","created":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T14:47:46Z","timestamp":1325688466000},"page":"2721-2725","source":"Crossref","is-referenced-by-count":58,"title":["Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws"],"prefix":"10.1007","volume":"23","author":[{"given":"Y.-D.","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.-J.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,5]]},"reference":[{"issue":"9","key":"1882_CR1","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hed.21380","volume":"33","author":"JJ Lee","year":"2010","unstructured":"Lee JJ, Cheng SJ, Jeng JH, Chiang CP, Lau HP, Kok SH (2010) Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy. Head Neck 33(9):1366\u20131371","journal-title":"Head Neck"},{"issue":"9","key":"1882_CR2","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/hed.21512","volume":"33","author":"A Kyrgidis","year":"2010","unstructured":"Kyrgidis A, Antoniades K (2010) Could teriparatide be the treatment for osteonecrosis of the jaws? Head Neck 33(9):1382\u20131383","journal-title":"Head Neck"},{"key":"1882_CR3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","volume":"65","author":"RP Harper","year":"2007","unstructured":"Harper RP, Fung E (2007) Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]. J Oral Maxillofac Surg 65:573\u2013580","journal-title":"J Oral Maxillofac Surg"},{"key":"1882_CR4","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMc1002684","volume":"363","author":"A Cheung","year":"2010","unstructured":"Cheung A, Seeman E (2010) Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. N Engl J Med 363:2473\u20132474","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"1882_CR5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2106\/JBJS.G.01443","volume":"90","author":"GL Barnes","year":"2008","unstructured":"Barnes GL, Kakar S, Vora S, Morgan EF, Gerstenfeld LC, Einhorn TA (2008) Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. J Bone Joint Surg Am 90(Suppl 1):120\u2013127","journal-title":"J Bone Joint Surg Am"},{"key":"1882_CR6","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1177\/00220345970760080901","volume":"76","author":"SC Miller","year":"1997","unstructured":"Miller SC, Hunziker J, Mecham M, Wronski TJ (1997) Intermittent parathyroid hormone administration stimulates bone formation in the mandibles of aged ovariectomized rats. J Dent Res 76:1471\u20131476","journal-title":"J Dent Res"},{"key":"1882_CR7","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","volume":"18","author":"Y Jiang","year":"2003","unstructured":"Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF (2003) Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932\u20131941","journal-title":"J Bone Miner Res"},{"key":"1882_CR8","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/en.2002-221061","volume":"144","author":"YL Ma","year":"2003","unstructured":"Ma YL, Bryant HU, Zeng Q, Schmidt A, Hoover J, Cole HW, Yao W, Jee WS, Sato M (2003) New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats. Endocrinology 144:2008\u20132015","journal-title":"Endocrinology"},{"key":"1882_CR9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","volume":"67","author":"ER Carlson","year":"2009","unstructured":"Carlson ER, Basile JD (2009) The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surgery 67:85\u201395","journal-title":"J Oral Maxillofac Surgery"},{"key":"1882_CR10","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00198-008-0604-4","volume":"19","author":"JR Curtis","year":"2008","unstructured":"Curtis JR, Westfall AO, Cheng H, Delzell E, Saag KG (2008) Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday. Osteoporosis Int 19:1613\u20131620","journal-title":"Osteoporosis Int"},{"key":"1882_CR11","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","volume":"296","author":"DM Black","year":"2006","unstructured":"Black DM, Schwartz AV, Ensrud KE et al (2006) Effects of continuing or stopping alendronate after 5\u00a0years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 296:2927\u20132938","journal-title":"JAMA"},{"key":"1882_CR12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","volume":"350","author":"HG Bone","year":"2004","unstructured":"Bone HG, Hosking D, Devogelaer JP et al (2004) Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189\u20131199","journal-title":"N Engl J Med"},{"key":"1882_CR13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0501.2010.01965.x","volume":"22","author":"YD Kwon","year":"2011","unstructured":"Kwon YD, Ohe JY, Kim DY, Chung DJ, Park YD (2011) Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers? Clin Oral Implants Res 22:100\u2013105","journal-title":"Clin Oral Implants Res"},{"key":"1882_CR14","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00198-009-0917-y","volume":"20","author":"BL Langdahl","year":"2009","unstructured":"Langdahl BL, Marin F, Shane E, Dobnig H, Zanchetta JR, Maricic M, Krohn K, See K, Warner MR (2009) Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status. Osteoporosis Int 20:2095\u20132104","journal-title":"Osteoporosis Int"},{"key":"1882_CR15","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","volume":"65","author":"RE Marx","year":"2007","unstructured":"Marx RE, Cillo JE Jr, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65:2397\u20132410","journal-title":"J Oral Maxillofac Surg"},{"key":"1882_CR16","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.joms.2008.01.054","volume":"66","author":"S Khosla","year":"2008","unstructured":"Khosla S, Burr D, Cauley J et al (2008) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 66:1320\u20131321, author reply 1321-1322","journal-title":"J Oral Maxillofac Surg"},{"key":"1882_CR17","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.joms.2009.04.067","volume":"67","author":"YD Kwon","year":"2009","unstructured":"Kwon YD, Kim DY, Ohe JY, Yoo JY, Walter C (2009) Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67:2644\u20132648","journal-title":"J Oral Maxillofac Surg"},{"key":"1882_CR18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00198-007-0502-1","volume":"19","author":"M Pazianas","year":"2008","unstructured":"Pazianas M, Blumentals WA, Miller PD (2008) Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker. Osteoporosis Int 19:773\u2013779","journal-title":"Osteoporosis Int"},{"key":"1882_CR19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00198-009-1001-3","volume":"21","author":"M Lateef","year":"2010","unstructured":"Lateef M, Baig M, Azhar A (2010) Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females. Osteoporosis Int 21:751\u2013755","journal-title":"Osteoporosis Int"},{"key":"1882_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/PL00004183","volume":"11","author":"E Fink","year":"2000","unstructured":"Fink E, Cormier C, Steinmetz P, Kindermans C, Le Bouc Y, Souberbielle JC (2000) Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy. Osteoporos Int 11:295\u2013303","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1882-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-011-1882-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1882-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:08:43Z","timestamp":1558609723000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-011-1882-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,5]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1882"],"URL":"https:\/\/doi.org\/10.1007\/s00198-011-1882-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,5]]}}}